Related Experiment Video
Updated: Jul 12, 2025

04:50
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
266
National consensus on a new resectability classification for perihilar cholangiocarcinoma - A modified Delphi method
Lynn E Nooijen1, Marieke T de Boer2, Andries E Braat3
1Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Surgery, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.
Summary
This study defined criteria for perihilar cholangiocarcinoma (pCCA) resectability. The new classification helps categorize patients for neoadjuvant therapy, improving treatment strategies for this challenging cancer.
Area of Science:
- Hepatobiliary surgery
- Surgical oncology
- Gastroenterology
Background:
- Lack of standardized definitions for resectable, borderline, and unresectable perihilar cholangiocarcinoma (pCCA).
- Need for clear criteria to guide patient selection for neoadjuvant or induction therapy studies in pCCA.
Purpose of the Study:
- To establish practical criteria for classifying pCCA resectability.
- To develop a classification system for patient stratification in future neoadjuvant therapy trials.
Main Methods:
- Modified DELPHI method employed with hepatobiliary surgeons from Dutch tertiary referral centers.
- Five online meetings and two surveys were conducted to discuss and reach consensus on resectability factors.
- Focus on vascular involvement of the future liver remnant (FLR) and feasibility of radical biliary resection.
Main Results:
- Consensus reached on 63% of the discussed statements after two surveys.
- Definition of clearly resectable pCCA: no significant vascular involvement (≤90°) of FLR and feasible radical biliary resection.
- Definition of clearly unresectable pCCA: non-reconstructable vascular involvement of FLR or non-feasible radical biliary resection.
- Borderline resectable pCCA defined as cases falling between clearly resectable and unresectable.
Conclusions:
- A practical and applicable classification for pCCA resectability (or explorability) was developed.
- This classification system facilitates patient categorization for neoadjuvant therapy studies.
- The study provides a foundation for more consistent and effective treatment planning in pCCA.

